ArticleDiseases (Basel, Switzerland)2024

CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways.

Ioannis A VoutsadakisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.